nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A7—Temsirolimus—kidney cancer	0.0712	0.101	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0712	0.101	CbGbCtD
Cilostazol—CYP3A5—Temsirolimus—kidney cancer	0.0534	0.0759	CbGbCtD
Cilostazol—CYP2D6—Temsirolimus—kidney cancer	0.0327	0.0466	CbGbCtD
Cilostazol—CYP3A4—Everolimus—kidney cancer	0.0308	0.0438	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0244	0.0347	CbGbCtD
Cilostazol—CYP3A7—Paclitaxel—kidney cancer	0.0244	0.0347	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0217	0.0309	CbGbCtD
Cilostazol—CYP3A7—Sorafenib—kidney cancer	0.0217	0.0309	CbGbCtD
Cilostazol—CYP3A7—Vincristine—kidney cancer	0.0211	0.03	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0211	0.03	CbGbCtD
Cilostazol—CYP1A2—Pazopanib—kidney cancer	0.0209	0.0297	CbGbCtD
Cilostazol—CYP3A4—Temsirolimus—kidney cancer	0.0208	0.0296	CbGbCtD
Cilostazol—CYP3A5—Erlotinib—kidney cancer	0.02	0.0285	CbGbCtD
Cilostazol—CYP3A5—Paclitaxel—kidney cancer	0.0183	0.0261	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0176	0.025	CbGbCtD
Cilostazol—CYP3A7—Sunitinib—kidney cancer	0.0176	0.025	CbGbCtD
Cilostazol—CYP2D6—Pazopanib—kidney cancer	0.0172	0.0245	CbGbCtD
Cilostazol—CYP3A5—Sorafenib—kidney cancer	0.0163	0.0231	CbGbCtD
Cilostazol—CYP3A5—Vincristine—kidney cancer	0.0158	0.0225	CbGbCtD
Cilostazol—CYP1A2—Erlotinib—kidney cancer	0.0149	0.0212	CbGbCtD
Cilostazol—CYP3A5—Sunitinib—kidney cancer	0.0132	0.0188	CbGbCtD
Cilostazol—CYP2C19—Sorafenib—kidney cancer	0.0131	0.0187	CbGbCtD
Cilostazol—CYP2D6—Erlotinib—kidney cancer	0.0123	0.0175	CbGbCtD
Cilostazol—CYP1A2—Sorafenib—kidney cancer	0.0121	0.0172	CbGbCtD
Cilostazol—CYP3A4—Pazopanib—kidney cancer	0.0109	0.0156	CbGbCtD
Cilostazol—CYP2D6—Sorafenib—kidney cancer	0.00998	0.0142	CbGbCtD
Cilostazol—CYP2D6—Vinblastine—kidney cancer	0.00986	0.014	CbGbCtD
Cilostazol—CYP3A4—Erlotinib—kidney cancer	0.00781	0.0111	CbGbCtD
Cilostazol—CYP3A4—Paclitaxel—kidney cancer	0.00715	0.0102	CbGbCtD
Cilostazol—CYP3A4—Sorafenib—kidney cancer	0.00635	0.00903	CbGbCtD
Cilostazol—CYP3A4—Vinblastine—kidney cancer	0.00627	0.00891	CbGbCtD
Cilostazol—CYP3A4—Vincristine—kidney cancer	0.00616	0.00876	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—kidney cancer	0.00606	0.00861	CbGbCtD
Cilostazol—CYP3A4—Sunitinib—kidney cancer	0.00514	0.00731	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—kidney cancer	0.00385	0.00548	CbGbCtD
Cilostazol—CYP2C19—urine—kidney cancer	0.00211	0.17	CbGeAlD
Cilostazol—CYP1A2—urine—kidney cancer	0.00172	0.139	CbGeAlD
Cilostazol—CYP3A4—urine—kidney cancer	0.00125	0.101	CbGeAlD
Cilostazol—CYP2D6—urine—kidney cancer	0.00123	0.0989	CbGeAlD
Cilostazol—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00108	0.0871	CbGeAlD
Cilostazol—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000925	0.0746	CbGeAlD
Cilostazol—PDE3A—cardiac atrium—kidney cancer	0.000853	0.0687	CbGeAlD
Cilostazol—CYP3A5—nephron tubule—kidney cancer	0.000448	0.0361	CbGeAlD
Cilostazol—CYP1A2—renal system—kidney cancer	0.000422	0.034	CbGeAlD
Cilostazol—CYP3A5—renal system—kidney cancer	0.000407	0.0328	CbGeAlD
Cilostazol—CYP3A5—kidney—kidney cancer	0.000393	0.0317	CbGeAlD
Cilostazol—CYP3A5—cortex of kidney—kidney cancer	0.000383	0.0309	CbGeAlD
Cilostazol—CYP3A4—renal system—kidney cancer	0.000305	0.0246	CbGeAlD
Cilostazol—CYP2D6—renal system—kidney cancer	0.0003	0.0242	CbGeAlD
Cilostazol—CYP3A4—kidney—kidney cancer	0.000295	0.0238	CbGeAlD
Cilostazol—CYP2D6—kidney—kidney cancer	0.00029	0.0234	CbGeAlD
Cilostazol—Malaise—Paclitaxel—kidney cancer	0.000109	0.000424	CcSEcCtD
Cilostazol—Cardiac failure—Doxorubicin—kidney cancer	0.000109	0.000423	CcSEcCtD
Cilostazol—Vertigo—Paclitaxel—kidney cancer	0.000109	0.000422	CcSEcCtD
Cilostazol—Syncope—Paclitaxel—kidney cancer	0.000108	0.000421	CcSEcCtD
Cilostazol—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000108	0.000421	CcSEcCtD
Cilostazol—Leukopenia—Paclitaxel—kidney cancer	0.000108	0.00042	CcSEcCtD
Cilostazol—Decreased appetite—Vincristine—kidney cancer	0.000108	0.00042	CcSEcCtD
Cilostazol—Pruritus—Sorafenib—kidney cancer	0.000108	0.00042	CcSEcCtD
Cilostazol—Vomiting—Erlotinib—kidney cancer	0.000108	0.000419	CcSEcCtD
Cilostazol—Erythema multiforme—Capecitabine—kidney cancer	0.000108	0.000419	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000107	0.000417	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Vincristine—kidney cancer	0.000107	0.000417	CcSEcCtD
Cilostazol—Rash—Erlotinib—kidney cancer	0.000107	0.000416	CcSEcCtD
Cilostazol—Dermatitis—Erlotinib—kidney cancer	0.000107	0.000415	CcSEcCtD
Cilostazol—Palpitations—Paclitaxel—kidney cancer	0.000107	0.000415	CcSEcCtD
Cilostazol—Insomnia—Gemcitabine—kidney cancer	0.000107	0.000414	CcSEcCtD
Cilostazol—Headache—Erlotinib—kidney cancer	0.000106	0.000413	CcSEcCtD
Cilostazol—Tinnitus—Capecitabine—kidney cancer	0.000106	0.000413	CcSEcCtD
Cilostazol—Loss of consciousness—Paclitaxel—kidney cancer	0.000106	0.000413	CcSEcCtD
Cilostazol—Pain—Vincristine—kidney cancer	0.000106	0.000413	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000106	0.000413	CcSEcCtD
Cilostazol—Diplopia—Doxorubicin—kidney cancer	0.000106	0.000413	CcSEcCtD
Cilostazol—Paraesthesia—Gemcitabine—kidney cancer	0.000106	0.000411	CcSEcCtD
Cilostazol—Cardiac disorder—Capecitabine—kidney cancer	0.000106	0.000411	CcSEcCtD
Cilostazol—Cough—Paclitaxel—kidney cancer	0.000105	0.00041	CcSEcCtD
Cilostazol—Asthenia—Sunitinib—kidney cancer	0.000105	0.000409	CcSEcCtD
Cilostazol—Dyspnoea—Gemcitabine—kidney cancer	0.000105	0.000408	CcSEcCtD
Cilostazol—Nausea—Vinblastine—kidney cancer	0.000105	0.000407	CcSEcCtD
Cilostazol—Nausea—Everolimus—kidney cancer	0.000104	0.000406	CcSEcCtD
Cilostazol—Diarrhoea—Sorafenib—kidney cancer	0.000104	0.000406	CcSEcCtD
Cilostazol—Hypertension—Paclitaxel—kidney cancer	0.000104	0.000406	CcSEcCtD
Cilostazol—Pruritus—Sunitinib—kidney cancer	0.000104	0.000404	CcSEcCtD
Cilostazol—Angiopathy—Capecitabine—kidney cancer	0.000103	0.000402	CcSEcCtD
Cilostazol—Myalgia—Paclitaxel—kidney cancer	0.000103	0.0004	CcSEcCtD
Cilostazol—Arthralgia—Paclitaxel—kidney cancer	0.000103	0.0004	CcSEcCtD
Cilostazol—Chest pain—Paclitaxel—kidney cancer	0.000103	0.0004	CcSEcCtD
Cilostazol—Mediastinal disorder—Capecitabine—kidney cancer	0.000103	0.000399	CcSEcCtD
Cilostazol—Anxiety—Paclitaxel—kidney cancer	0.000103	0.000398	CcSEcCtD
Cilostazol—Face oedema—Doxorubicin—kidney cancer	0.000103	0.000398	CcSEcCtD
Cilostazol—Decreased appetite—Gemcitabine—kidney cancer	0.000102	0.000398	CcSEcCtD
Cilostazol—Chills—Capecitabine—kidney cancer	0.000102	0.000397	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000102	0.000397	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000102	0.000395	CcSEcCtD
Cilostazol—Discomfort—Paclitaxel—kidney cancer	0.000102	0.000395	CcSEcCtD
Cilostazol—Gastrointestinal pain—Vincristine—kidney cancer	0.000102	0.000395	CcSEcCtD
Cilostazol—Cardiac arrest—Doxorubicin—kidney cancer	0.000101	0.000392	CcSEcCtD
Cilostazol—Dizziness—Sorafenib—kidney cancer	0.000101	0.000392	CcSEcCtD
Cilostazol—Pain—Gemcitabine—kidney cancer	0.000101	0.000392	CcSEcCtD
Cilostazol—Nausea—Erlotinib—kidney cancer	0.000101	0.000392	CcSEcCtD
Cilostazol—Diarrhoea—Sunitinib—kidney cancer	0.0001	0.00039	CcSEcCtD
Cilostazol—Asthenia—Dactinomycin—kidney cancer	9.97e-05	0.000388	CcSEcCtD
Cilostazol—Blood creatinine increased—Doxorubicin—kidney cancer	9.95e-05	0.000387	CcSEcCtD
Cilostazol—Oedema—Paclitaxel—kidney cancer	9.87e-05	0.000383	CcSEcCtD
Cilostazol—Body temperature increased—Vincristine—kidney cancer	9.82e-05	0.000382	CcSEcCtD
Cilostazol—Abdominal pain—Vincristine—kidney cancer	9.82e-05	0.000382	CcSEcCtD
Cilostazol—Liver function test abnormal—Doxorubicin—kidney cancer	9.8e-05	0.000381	CcSEcCtD
Cilostazol—Infection—Paclitaxel—kidney cancer	9.8e-05	0.000381	CcSEcCtD
Cilostazol—Flatulence—Capecitabine—kidney cancer	9.77e-05	0.00038	CcSEcCtD
Cilostazol—Dry skin—Doxorubicin—kidney cancer	9.73e-05	0.000378	CcSEcCtD
Cilostazol—Dizziness—Sunitinib—kidney cancer	9.71e-05	0.000377	CcSEcCtD
Cilostazol—Feeling abnormal—Gemcitabine—kidney cancer	9.71e-05	0.000377	CcSEcCtD
Cilostazol—Shock—Paclitaxel—kidney cancer	9.71e-05	0.000377	CcSEcCtD
Cilostazol—Vomiting—Sorafenib—kidney cancer	9.7e-05	0.000377	CcSEcCtD
Cilostazol—Orthostatic hypotension—Doxorubicin—kidney cancer	9.7e-05	0.000377	CcSEcCtD
Cilostazol—Nervous system disorder—Paclitaxel—kidney cancer	9.67e-05	0.000376	CcSEcCtD
Cilostazol—Thrombocytopenia—Paclitaxel—kidney cancer	9.66e-05	0.000375	CcSEcCtD
Cilostazol—Tachycardia—Paclitaxel—kidney cancer	9.63e-05	0.000374	CcSEcCtD
Cilostazol—Rash—Sorafenib—kidney cancer	9.62e-05	0.000374	CcSEcCtD
Cilostazol—Dermatitis—Sorafenib—kidney cancer	9.61e-05	0.000374	CcSEcCtD
Cilostazol—Back pain—Capecitabine—kidney cancer	9.6e-05	0.000373	CcSEcCtD
Cilostazol—Skin disorder—Paclitaxel—kidney cancer	9.58e-05	0.000372	CcSEcCtD
Cilostazol—Headache—Sorafenib—kidney cancer	9.56e-05	0.000371	CcSEcCtD
Cilostazol—Muscle spasms—Capecitabine—kidney cancer	9.54e-05	0.000371	CcSEcCtD
Cilostazol—Diarrhoea—Dactinomycin—kidney cancer	9.51e-05	0.00037	CcSEcCtD
Cilostazol—Anorexia—Paclitaxel—kidney cancer	9.4e-05	0.000365	CcSEcCtD
Cilostazol—Gastritis—Doxorubicin—kidney cancer	9.4e-05	0.000365	CcSEcCtD
Cilostazol—Vomiting—Sunitinib—kidney cancer	9.34e-05	0.000363	CcSEcCtD
Cilostazol—Body temperature increased—Gemcitabine—kidney cancer	9.31e-05	0.000362	CcSEcCtD
Cilostazol—Rash—Sunitinib—kidney cancer	9.26e-05	0.00036	CcSEcCtD
Cilostazol—Dermatitis—Sunitinib—kidney cancer	9.25e-05	0.000359	CcSEcCtD
Cilostazol—Hypotension—Paclitaxel—kidney cancer	9.22e-05	0.000358	CcSEcCtD
Cilostazol—Ill-defined disorder—Capecitabine—kidney cancer	9.2e-05	0.000358	CcSEcCtD
Cilostazol—Headache—Sunitinib—kidney cancer	9.2e-05	0.000357	CcSEcCtD
Cilostazol—Influenza—Doxorubicin—kidney cancer	9.18e-05	0.000357	CcSEcCtD
Cilostazol—Asthma—Doxorubicin—kidney cancer	9.18e-05	0.000357	CcSEcCtD
Cilostazol—Anaemia—Capecitabine—kidney cancer	9.17e-05	0.000356	CcSEcCtD
Cilostazol—Nausea—Sorafenib—kidney cancer	9.06e-05	0.000352	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	8.99e-05	0.000349	CcSEcCtD
Cilostazol—Malaise—Capecitabine—kidney cancer	8.95e-05	0.000348	CcSEcCtD
Cilostazol—Angina pectoris—Doxorubicin—kidney cancer	8.94e-05	0.000347	CcSEcCtD
Cilostazol—Insomnia—Paclitaxel—kidney cancer	8.92e-05	0.000347	CcSEcCtD
Cilostazol—Vertigo—Capecitabine—kidney cancer	8.91e-05	0.000346	CcSEcCtD
Cilostazol—Asthenia—Vincristine—kidney cancer	8.91e-05	0.000346	CcSEcCtD
Cilostazol—Syncope—Capecitabine—kidney cancer	8.9e-05	0.000346	CcSEcCtD
Cilostazol—Leukopenia—Capecitabine—kidney cancer	8.88e-05	0.000345	CcSEcCtD
Cilostazol—Paraesthesia—Paclitaxel—kidney cancer	8.86e-05	0.000344	CcSEcCtD
Cilostazol—Vomiting—Dactinomycin—kidney cancer	8.84e-05	0.000343	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—kidney cancer	8.83e-05	0.000343	CcSEcCtD
Cilostazol—Dyspnoea—Paclitaxel—kidney cancer	8.8e-05	0.000342	CcSEcCtD
Cilostazol—Palpitations—Capecitabine—kidney cancer	8.77e-05	0.000341	CcSEcCtD
Cilostazol—Rash—Dactinomycin—kidney cancer	8.77e-05	0.000341	CcSEcCtD
Cilostazol—Nausea—Sunitinib—kidney cancer	8.72e-05	0.000339	CcSEcCtD
Cilostazol—Loss of consciousness—Capecitabine—kidney cancer	8.72e-05	0.000339	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—kidney cancer	8.72e-05	0.000339	CcSEcCtD
Cilostazol—Dyspepsia—Paclitaxel—kidney cancer	8.68e-05	0.000337	CcSEcCtD
Cilostazol—Cough—Capecitabine—kidney cancer	8.66e-05	0.000336	CcSEcCtD
Cilostazol—Decreased appetite—Paclitaxel—kidney cancer	8.58e-05	0.000333	CcSEcCtD
Cilostazol—Hypertension—Capecitabine—kidney cancer	8.56e-05	0.000333	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Paclitaxel—kidney cancer	8.52e-05	0.000331	CcSEcCtD
Cilostazol—Diarrhoea—Vincristine—kidney cancer	8.5e-05	0.00033	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—kidney cancer	8.48e-05	0.000329	CcSEcCtD
Cilostazol—Asthenia—Gemcitabine—kidney cancer	8.45e-05	0.000328	CcSEcCtD
Cilostazol—Arthralgia—Capecitabine—kidney cancer	8.45e-05	0.000328	CcSEcCtD
Cilostazol—Myalgia—Capecitabine—kidney cancer	8.45e-05	0.000328	CcSEcCtD
Cilostazol—Chest pain—Capecitabine—kidney cancer	8.45e-05	0.000328	CcSEcCtD
Cilostazol—Pain—Paclitaxel—kidney cancer	8.44e-05	0.000328	CcSEcCtD
Cilostazol—Anxiety—Capecitabine—kidney cancer	8.42e-05	0.000327	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	8.39e-05	0.000326	CcSEcCtD
Cilostazol—Discomfort—Capecitabine—kidney cancer	8.34e-05	0.000324	CcSEcCtD
Cilostazol—Pruritus—Gemcitabine—kidney cancer	8.34e-05	0.000324	CcSEcCtD
Cilostazol—Nausea—Dactinomycin—kidney cancer	8.26e-05	0.000321	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—kidney cancer	8.23e-05	0.00032	CcSEcCtD
Cilostazol—Dizziness—Vincristine—kidney cancer	8.21e-05	0.000319	CcSEcCtD
Cilostazol—Feeling abnormal—Paclitaxel—kidney cancer	8.13e-05	0.000316	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	8.11e-05	0.000315	CcSEcCtD
Cilostazol—Oedema—Capecitabine—kidney cancer	8.1e-05	0.000315	CcSEcCtD
Cilostazol—Gastrointestinal pain—Paclitaxel—kidney cancer	8.07e-05	0.000313	CcSEcCtD
Cilostazol—Diarrhoea—Gemcitabine—kidney cancer	8.06e-05	0.000313	CcSEcCtD
Cilostazol—Infection—Capecitabine—kidney cancer	8.04e-05	0.000313	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—kidney cancer	7.98e-05	0.00031	CcSEcCtD
Cilostazol—Shock—Capecitabine—kidney cancer	7.96e-05	0.000309	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—kidney cancer	7.95e-05	0.000309	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—kidney cancer	7.95e-05	0.000309	CcSEcCtD
Cilostazol—Nervous system disorder—Capecitabine—kidney cancer	7.94e-05	0.000309	CcSEcCtD
Cilostazol—Thrombocytopenia—Capecitabine—kidney cancer	7.93e-05	0.000308	CcSEcCtD
Cilostazol—Tachycardia—Capecitabine—kidney cancer	7.9e-05	0.000307	CcSEcCtD
Cilostazol—Vomiting—Vincristine—kidney cancer	7.9e-05	0.000307	CcSEcCtD
Cilostazol—Skin disorder—Capecitabine—kidney cancer	7.86e-05	0.000306	CcSEcCtD
Cilostazol—Urticaria—Paclitaxel—kidney cancer	7.84e-05	0.000305	CcSEcCtD
Cilostazol—Rash—Vincristine—kidney cancer	7.83e-05	0.000304	CcSEcCtD
Cilostazol—Dermatitis—Vincristine—kidney cancer	7.82e-05	0.000304	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—kidney cancer	7.8e-05	0.000303	CcSEcCtD
Cilostazol—Body temperature increased—Paclitaxel—kidney cancer	7.8e-05	0.000303	CcSEcCtD
Cilostazol—Abdominal pain—Paclitaxel—kidney cancer	7.8e-05	0.000303	CcSEcCtD
Cilostazol—Headache—Vincristine—kidney cancer	7.78e-05	0.000302	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—kidney cancer	7.74e-05	0.000301	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—kidney cancer	7.72e-05	0.0003	CcSEcCtD
Cilostazol—Anorexia—Capecitabine—kidney cancer	7.72e-05	0.0003	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—kidney cancer	7.68e-05	0.000298	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—kidney cancer	7.64e-05	0.000297	CcSEcCtD
Cilostazol—Hypotension—Capecitabine—kidney cancer	7.56e-05	0.000294	CcSEcCtD
Cilostazol—Vomiting—Gemcitabine—kidney cancer	7.49e-05	0.000291	CcSEcCtD
Cilostazol—Rash—Gemcitabine—kidney cancer	7.43e-05	0.000289	CcSEcCtD
Cilostazol—Dermatitis—Gemcitabine—kidney cancer	7.42e-05	0.000288	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—kidney cancer	7.38e-05	0.000287	CcSEcCtD
Cilostazol—Headache—Gemcitabine—kidney cancer	7.38e-05	0.000287	CcSEcCtD
Cilostazol—Nausea—Vincristine—kidney cancer	7.38e-05	0.000287	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.38e-05	0.000287	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—kidney cancer	7.36e-05	0.000286	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—kidney cancer	7.35e-05	0.000285	CcSEcCtD
Cilostazol—Insomnia—Capecitabine—kidney cancer	7.32e-05	0.000285	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—kidney cancer	7.31e-05	0.000284	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—kidney cancer	7.29e-05	0.000283	CcSEcCtD
Cilostazol—Paraesthesia—Capecitabine—kidney cancer	7.27e-05	0.000282	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—kidney cancer	7.24e-05	0.000281	CcSEcCtD
Cilostazol—Dyspnoea—Capecitabine—kidney cancer	7.22e-05	0.00028	CcSEcCtD
Cilostazol—Dyspepsia—Capecitabine—kidney cancer	7.13e-05	0.000277	CcSEcCtD
Cilostazol—Asthenia—Paclitaxel—kidney cancer	7.08e-05	0.000275	CcSEcCtD
Cilostazol—Decreased appetite—Capecitabine—kidney cancer	7.04e-05	0.000273	CcSEcCtD
Cilostazol—Nausea—Gemcitabine—kidney cancer	7e-05	0.000272	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Capecitabine—kidney cancer	6.99e-05	0.000272	CcSEcCtD
Cilostazol—Pruritus—Paclitaxel—kidney cancer	6.98e-05	0.000271	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—kidney cancer	6.95e-05	0.00027	CcSEcCtD
Cilostazol—Pain—Capecitabine—kidney cancer	6.92e-05	0.000269	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—kidney cancer	6.85e-05	0.000266	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—kidney cancer	6.82e-05	0.000265	CcSEcCtD
Cilostazol—Diarrhoea—Paclitaxel—kidney cancer	6.75e-05	0.000262	CcSEcCtD
Cilostazol—Feeling abnormal—Capecitabine—kidney cancer	6.67e-05	0.000259	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—kidney cancer	6.66e-05	0.000259	CcSEcCtD
Cilostazol—Gastrointestinal pain—Capecitabine—kidney cancer	6.62e-05	0.000257	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—kidney cancer	6.62e-05	0.000257	CcSEcCtD
Cilostazol—Chills—Doxorubicin—kidney cancer	6.59e-05	0.000256	CcSEcCtD
Cilostazol—Dizziness—Paclitaxel—kidney cancer	6.52e-05	0.000253	CcSEcCtD
Cilostazol—Urticaria—Capecitabine—kidney cancer	6.43e-05	0.00025	CcSEcCtD
Cilostazol—Abdominal pain—Capecitabine—kidney cancer	6.4e-05	0.000249	CcSEcCtD
Cilostazol—Body temperature increased—Capecitabine—kidney cancer	6.4e-05	0.000249	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—kidney cancer	6.3e-05	0.000245	CcSEcCtD
Cilostazol—Vomiting—Paclitaxel—kidney cancer	6.27e-05	0.000244	CcSEcCtD
Cilostazol—Rash—Paclitaxel—kidney cancer	6.22e-05	0.000242	CcSEcCtD
Cilostazol—Dermatitis—Paclitaxel—kidney cancer	6.21e-05	0.000241	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—kidney cancer	6.19e-05	0.00024	CcSEcCtD
Cilostazol—Headache—Paclitaxel—kidney cancer	6.18e-05	0.00024	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—kidney cancer	6.15e-05	0.000239	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—kidney cancer	5.93e-05	0.000231	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—kidney cancer	5.91e-05	0.00023	CcSEcCtD
Cilostazol—Nausea—Paclitaxel—kidney cancer	5.86e-05	0.000228	CcSEcCtD
Cilostazol—Asthenia—Capecitabine—kidney cancer	5.81e-05	0.000226	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—kidney cancer	5.77e-05	0.000224	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—kidney cancer	5.74e-05	0.000223	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—kidney cancer	5.73e-05	0.000223	CcSEcCtD
Cilostazol—Pruritus—Capecitabine—kidney cancer	5.73e-05	0.000223	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—kidney cancer	5.72e-05	0.000222	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—kidney cancer	5.65e-05	0.00022	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—kidney cancer	5.62e-05	0.000218	CcSEcCtD
Cilostazol—Cough—Doxorubicin—kidney cancer	5.58e-05	0.000217	CcSEcCtD
Cilostazol—Diarrhoea—Capecitabine—kidney cancer	5.54e-05	0.000215	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—kidney cancer	5.52e-05	0.000215	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—kidney cancer	5.44e-05	0.000212	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—kidney cancer	5.44e-05	0.000212	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—kidney cancer	5.44e-05	0.000212	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—kidney cancer	5.42e-05	0.000211	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.41e-05	0.00021	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—kidney cancer	5.38e-05	0.000209	CcSEcCtD
Cilostazol—Dizziness—Capecitabine—kidney cancer	5.35e-05	0.000208	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—kidney cancer	5.22e-05	0.000203	CcSEcCtD
Cilostazol—Infection—Doxorubicin—kidney cancer	5.18e-05	0.000201	CcSEcCtD
Cilostazol—Vomiting—Capecitabine—kidney cancer	5.15e-05	0.0002	CcSEcCtD
Cilostazol—Shock—Doxorubicin—kidney cancer	5.13e-05	0.0002	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—kidney cancer	5.12e-05	0.000199	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—kidney cancer	5.11e-05	0.000199	CcSEcCtD
Cilostazol—Rash—Capecitabine—kidney cancer	5.1e-05	0.000198	CcSEcCtD
Cilostazol—Dermatitis—Capecitabine—kidney cancer	5.1e-05	0.000198	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—kidney cancer	5.09e-05	0.000198	CcSEcCtD
Cilostazol—Headache—Capecitabine—kidney cancer	5.07e-05	0.000197	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—kidney cancer	5.07e-05	0.000197	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—kidney cancer	4.97e-05	0.000193	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—kidney cancer	4.88e-05	0.000189	CcSEcCtD
Cilostazol—Nausea—Capecitabine—kidney cancer	4.81e-05	0.000187	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.75e-05	0.000185	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—kidney cancer	4.72e-05	0.000183	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—kidney cancer	4.69e-05	0.000182	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—kidney cancer	4.65e-05	0.000181	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—kidney cancer	4.59e-05	0.000178	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—kidney cancer	4.54e-05	0.000176	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.51e-05	0.000175	CcSEcCtD
Cilostazol—Pain—Doxorubicin—kidney cancer	4.46e-05	0.000173	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—kidney cancer	4.3e-05	0.000167	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—kidney cancer	4.27e-05	0.000166	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—kidney cancer	4.15e-05	0.000161	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—kidney cancer	4.13e-05	0.00016	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—kidney cancer	4.13e-05	0.00016	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—kidney cancer	3.74e-05	0.000145	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—kidney cancer	3.69e-05	0.000143	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—kidney cancer	3.57e-05	0.000139	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—kidney cancer	3.45e-05	0.000134	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—kidney cancer	3.32e-05	0.000129	CcSEcCtD
Cilostazol—Rash—Doxorubicin—kidney cancer	3.29e-05	0.000128	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—kidney cancer	3.29e-05	0.000128	CcSEcCtD
Cilostazol—Headache—Doxorubicin—kidney cancer	3.27e-05	0.000127	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—kidney cancer	3.1e-05	0.00012	CcSEcCtD
Cilostazol—CYP3A5—Metabolism—FH—kidney cancer	2e-05	0.00074	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—APRT—kidney cancer	2e-05	0.00074	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—MAPK3—kidney cancer	1.93e-05	0.000713	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CCBL1—kidney cancer	1.92e-05	0.00071	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CA9—kidney cancer	1.92e-05	0.00071	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.88e-05	0.000697	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GPC3—kidney cancer	1.88e-05	0.000696	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PDHB—kidney cancer	1.88e-05	0.000695	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—POMC—kidney cancer	1.87e-05	0.000692	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ACY1—kidney cancer	1.87e-05	0.000692	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—POMC—kidney cancer	1.86e-05	0.000688	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.86e-05	0.000687	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—MAPK1—kidney cancer	1.83e-05	0.000678	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CA2—kidney cancer	1.83e-05	0.000677	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALAD—kidney cancer	1.78e-05	0.00066	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CCBL1—kidney cancer	1.77e-05	0.000653	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ST3GAL2—kidney cancer	1.74e-05	0.000644	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.74e-05	0.000642	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—KRAS—kidney cancer	1.73e-05	0.000641	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.73e-05	0.00064	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.71e-05	0.000632	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.7e-05	0.000629	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.66e-05	0.000616	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPAT—kidney cancer	1.66e-05	0.000616	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IGF2—kidney cancer	1.65e-05	0.000609	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.64e-05	0.000608	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.64e-05	0.000607	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN2B—kidney cancer	1.64e-05	0.000607	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CRABP1—kidney cancer	1.63e-05	0.000604	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PGK1—kidney cancer	1.63e-05	0.000603	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.63e-05	0.000603	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.63e-05	0.000602	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.62e-05	0.000599	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—LDHB—kidney cancer	1.6e-05	0.000592	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.6e-05	0.00059	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IGF1R—kidney cancer	1.59e-05	0.000589	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—PIK3CA—kidney cancer	1.59e-05	0.000589	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PDHB—kidney cancer	1.59e-05	0.000588	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—POMC—kidney cancer	1.59e-05	0.000587	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—FH—kidney cancer	1.55e-05	0.000572	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—APRT—kidney cancer	1.55e-05	0.000572	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TP53—kidney cancer	1.54e-05	0.000569	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—RAF1—kidney cancer	1.53e-05	0.000568	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPAT—kidney cancer	1.53e-05	0.000566	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.53e-05	0.000566	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ITPR2—kidney cancer	1.52e-05	0.000561	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—IL2—kidney cancer	1.52e-05	0.00056	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.51e-05	0.000559	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CCBL1—kidney cancer	1.5e-05	0.000553	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GPC3—kidney cancer	1.45e-05	0.000538	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ACY1—kidney cancer	1.44e-05	0.000534	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—FH—kidney cancer	1.42e-05	0.000526	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—APRT—kidney cancer	1.42e-05	0.000526	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CA2—kidney cancer	1.42e-05	0.000523	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CA9—kidney cancer	1.39e-05	0.000513	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTT1—kidney cancer	1.38e-05	0.000512	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ACHE—kidney cancer	1.38e-05	0.000512	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALAD—kidney cancer	1.38e-05	0.00051	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL2—kidney cancer	1.38e-05	0.000509	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.35e-05	0.0005	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.35e-05	0.000498	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GPC3—kidney cancer	1.34e-05	0.000495	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.32e-05	0.000487	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HIF1A—kidney cancer	1.31e-05	0.000485	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—SCARB1—kidney cancer	1.31e-05	0.000484	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TSC2—kidney cancer	1.31e-05	0.000484	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CA2—kidney cancer	1.3e-05	0.000481	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.3e-05	0.00048	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPAT—kidney cancer	1.3e-05	0.00048	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS1—kidney cancer	1.3e-05	0.000479	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.28e-05	0.000474	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PSMD7—kidney cancer	1.27e-05	0.00047	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALAD—kidney cancer	1.27e-05	0.000469	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.27e-05	0.000469	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.26e-05	0.000467	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PGK1—kidney cancer	1.26e-05	0.000467	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KDR—kidney cancer	1.25e-05	0.000464	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.24e-05	0.000458	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—LDHB—kidney cancer	1.24e-05	0.000457	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PDHB—kidney cancer	1.23e-05	0.000454	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—POMC—kidney cancer	1.22e-05	0.000453	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.21e-05	0.000448	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—APRT—kidney cancer	1.21e-05	0.000446	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—FH—kidney cancer	1.21e-05	0.000446	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—BCHE—kidney cancer	1.21e-05	0.000446	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.19e-05	0.00044	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CRABP1—kidney cancer	1.18e-05	0.000436	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.18e-05	0.000436	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PGK1—kidney cancer	1.16e-05	0.000429	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.16e-05	0.000429	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—APC—kidney cancer	1.16e-05	0.000427	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KIT—kidney cancer	1.16e-05	0.000427	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CCBL1—kidney cancer	1.15e-05	0.000427	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.15e-05	0.000425	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—LDHB—kidney cancer	1.14e-05	0.000421	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GPC3—kidney cancer	1.13e-05	0.000419	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—MAPK3—kidney cancer	1.11e-05	0.000409	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CA2—kidney cancer	1.1e-05	0.000408	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—POMC—kidney cancer	1.1e-05	0.000407	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ITPR2—kidney cancer	1.1e-05	0.000406	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—BRAF—kidney cancer	1.09e-05	0.000402	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALAD—kidney cancer	1.07e-05	0.000397	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CA9—kidney cancer	1.07e-05	0.000397	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—MAPK1—kidney cancer	1.05e-05	0.000389	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.05e-05	0.000388	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.05e-05	0.000388	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.03e-05	0.000379	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PIK3CA—kidney cancer	1.01e-05	0.000372	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPAT—kidney cancer	1e-05	0.00037	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GLIPR1—kidney cancer	1e-05	0.00037	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTT1—kidney cancer	1e-05	0.00037	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ACHE—kidney cancer	1e-05	0.00037	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—KRAS—kidney cancer	9.94e-06	0.000368	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CA9—kidney cancer	9.87e-06	0.000365	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PGK1—kidney cancer	9.83e-06	0.000363	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC5A3—kidney cancer	9.83e-06	0.000363	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—LDHB—kidney cancer	9.64e-06	0.000356	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTP1—kidney cancer	9.59e-06	0.000355	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SCARB1—kidney cancer	9.47e-06	0.00035	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS1—kidney cancer	9.37e-06	0.000347	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—FH—kidney cancer	9.31e-06	0.000344	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—APRT—kidney cancer	9.31e-06	0.000344	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PSMD7—kidney cancer	9.19e-06	0.00034	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CA—kidney cancer	9.13e-06	0.000338	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CRABP1—kidney cancer	9.12e-06	0.000337	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ABCB1—kidney cancer	9.08e-06	0.000336	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RAF1—kidney cancer	9.07e-06	0.000335	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RELA—kidney cancer	9.03e-06	0.000334	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ERBB2—kidney cancer	8.97e-06	0.000332	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MTOR—kidney cancer	8.85e-06	0.000327	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTM1—kidney cancer	8.81e-06	0.000326	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPC3—kidney cancer	8.75e-06	0.000324	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—BCHE—kidney cancer	8.71e-06	0.000322	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SLC5A5—kidney cancer	8.61e-06	0.000318	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CA2—kidney cancer	8.51e-06	0.000315	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ITPR2—kidney cancer	8.48e-06	0.000314	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CRABP1—kidney cancer	8.39e-06	0.00031	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CA9—kidney cancer	8.36e-06	0.000309	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP1A1—kidney cancer	8.35e-06	0.000309	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SLC2A1—kidney cancer	8.31e-06	0.000307	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN1B—kidney cancer	8.31e-06	0.000307	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALAD—kidney cancer	8.29e-06	0.000307	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.17e-06	0.000302	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL2—kidney cancer	8.13e-06	0.000301	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.1e-06	0.000299	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCND1—kidney cancer	7.92e-06	0.000293	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.91e-06	0.000293	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JUN—kidney cancer	7.91e-06	0.000292	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CTNNB1—kidney cancer	7.85e-06	0.00029	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.82e-06	0.000289	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ITPR2—kidney cancer	7.8e-06	0.000288	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ACHE—kidney cancer	7.73e-06	0.000286	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTT1—kidney cancer	7.73e-06	0.000286	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTEN—kidney cancer	7.65e-06	0.000283	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PGK1—kidney cancer	7.59e-06	0.000281	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.59e-06	0.000281	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—LDHB—kidney cancer	7.44e-06	0.000275	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SCARB1—kidney cancer	7.32e-06	0.000271	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS1—kidney cancer	7.25e-06	0.000268	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ACHE—kidney cancer	7.11e-06	0.000263	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—kidney cancer	7.11e-06	0.000263	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CRABP1—kidney cancer	7.11e-06	0.000263	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PSMD7—kidney cancer	7.11e-06	0.000263	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—kidney cancer	6.93e-06	0.000256	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—kidney cancer	6.91e-06	0.000255	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—BCHE—kidney cancer	6.74e-06	0.000249	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SCARB1—kidney cancer	6.73e-06	0.000249	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS1—kidney cancer	6.66e-06	0.000246	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC5A5—kidney cancer	6.65e-06	0.000246	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ITPR2—kidney cancer	6.61e-06	0.000244	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ABCB1—kidney cancer	6.56e-06	0.000243	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PSMD7—kidney cancer	6.53e-06	0.000242	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK3—kidney cancer	6.53e-06	0.000242	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CA9—kidney cancer	6.45e-06	0.000239	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC2A1—kidney cancer	6.43e-06	0.000238	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—kidney cancer	6.37e-06	0.000236	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—kidney cancer	6.36e-06	0.000235	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.23e-06	0.000231	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—POMC—kidney cancer	6.23e-06	0.00023	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK1—kidney cancer	6.22e-06	0.00023	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—BCHE—kidney cancer	6.2e-06	0.000229	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.12e-06	0.000226	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.09e-06	0.000225	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP1A1—kidney cancer	6.04e-06	0.000223	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—kidney cancer	6.02e-06	0.000223	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ACHE—kidney cancer	6.02e-06	0.000223	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC2A1—kidney cancer	5.91e-06	0.000219	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KRAS—kidney cancer	5.87e-06	0.000217	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SCARB1—kidney cancer	5.7e-06	0.000211	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS1—kidney cancer	5.65e-06	0.000209	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PSMD7—kidney cancer	5.54e-06	0.000205	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CRABP1—kidney cancer	5.48e-06	0.000203	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.44e-06	0.000201	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CA—kidney cancer	5.4e-06	0.0002	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—kidney cancer	5.36e-06	0.000198	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—BCHE—kidney cancer	5.25e-06	0.000194	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—kidney cancer	5.22e-06	0.000193	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.18e-06	0.000192	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ITPR2—kidney cancer	5.1e-06	0.000189	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCB1—kidney cancer	5.07e-06	0.000188	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.01e-06	0.000185	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—kidney cancer	4.97e-06	0.000184	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—kidney cancer	4.93e-06	0.000182	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—kidney cancer	4.92e-06	0.000182	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.86e-06	0.00018	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.67e-06	0.000173	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCB1—kidney cancer	4.67e-06	0.000173	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ACHE—kidney cancer	4.65e-06	0.000172	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—kidney cancer	4.65e-06	0.000172	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—kidney cancer	4.53e-06	0.000168	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—POMC—kidney cancer	4.5e-06	0.000167	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SCARB1—kidney cancer	4.4e-06	0.000163	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS1—kidney cancer	4.36e-06	0.000161	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTEN—kidney cancer	4.33e-06	0.00016	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.29e-06	0.000159	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PSMD7—kidney cancer	4.27e-06	0.000158	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.24e-06	0.000157	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—kidney cancer	4.18e-06	0.000154	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—BCHE—kidney cancer	4.05e-06	0.00015	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC5A5—kidney cancer	4e-06	0.000148	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCB1—kidney cancer	3.95e-06	0.000146	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.86e-06	0.000143	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—kidney cancer	3.84e-06	0.000142	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.84e-06	0.000142	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.64e-06	0.000135	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—kidney cancer	3.59e-06	0.000133	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—POMC—kidney cancer	3.48e-06	0.000129	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—kidney cancer	3.22e-06	0.000119	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—POMC—kidney cancer	3.2e-06	0.000118	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTEN—kidney cancer	3.13e-06	0.000116	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CA—kidney cancer	3.06e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCB1—kidney cancer	3.05e-06	0.000113	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.99e-06	0.000111	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—kidney cancer	2.96e-06	0.00011	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.81e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—kidney cancer	2.78e-06	0.000103	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—POMC—kidney cancer	2.71e-06	0.0001	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—kidney cancer	2.55e-06	9.44e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTEN—kidney cancer	2.42e-06	8.95e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTEN—kidney cancer	2.23e-06	8.24e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.21e-06	8.17e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—kidney cancer	2.16e-06	8e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—POMC—kidney cancer	2.09e-06	7.74e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTEN—kidney cancer	1.89e-06	6.98e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.71e-06	6.32e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—kidney cancer	1.67e-06	6.17e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.57e-06	5.81e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTEN—kidney cancer	1.46e-06	5.38e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.33e-06	4.92e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.03e-06	3.8e-05	CbGpPWpGaD
